Displaying 13 - 24 of 26
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
1

Sobi: When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD) - ILC 2021

View
Cirrhosis & Complications
4

Shionogi:  Raising platelets – the growing evidence supporting the use of TPO-RAs for addressing severe thrombocytopenia prior to invasive procedures in patients with chronic liver disease - ILC 2021

View
Cirrhosis & Complications
4

Shionogi:  Raising platelets – the growing evidence supporting the use of TPO-RAs for addressing severe thrombocytopenia prior to invasive procedures in patients with chronic liver disease - ILC 2021

View
Cirrhosis & Complications
4

Shionogi:  Raising platelets – the growing evidence supporting the use of TPO-RAs for addressing severe thrombocytopenia prior to invasive procedures in patients with chronic liver disease - ILC 2021

View
Cirrhosis & Complications
4

Shionogi:  Raising platelets – the growing evidence supporting the use of TPO-RAs for addressing severe thrombocytopenia prior to invasive procedures in patients with chronic liver disease - ILC 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View